Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ARFGEF1 divergent transcript (ARFGEF1-DT, AC021321.1) is a non-coding RNA classified as a divergent or antisense transcript relative to the ARFGEF1 gene. There is currently no evidence in the literature supporting a direct biological function, therapeutic target role, or association with druggable activities for ARFGEF1-DT. Unlike the protein-coding ARFGEF1 gene (which encodes a guanine nucleotide exchange factor involved in membrane trafficking[3]), ARFGEF1-DT's role, if any, is currently unknown. As a non-coding RNA, it might act in gene regulation or RNA-mediated processes, but no such evidence has been specifically described or linked to human disease or therapy based on current information.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ARFGEF1 divergent transcript (ARFGEF1-DT).